ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatocellular carcinoma"

  • 2018 American Transplant Congress

    Utility of Combining Stereotactic Body Radiation Therapy (SBRT) to Transarterial Chemoembolization as Destination Therapy for Hepatocellular Cancer (HCC) within Milan Criteria

    A. Murali, K. Soota, M. Karwal, T. Tanaka, J. Dunkelberg, M. Voigt.

    University of Iowa Hospitals and Clinics, Iowa City.

    Limited data are available on the effect of SBRT in patients with HCC within Milan. We aimed to compare TACE followed by SBRT with TACE…
  • 2018 American Transplant Congress

    Radiation Exposure to the Transplant Surgeon: A Case Study of Recent Yttrium-90 Treatment in an Explanted Liver

    M. Decoteau,1 P. Lewis,1 S. Steuterman,2 R. Schaffer,1 J. Fisher,1 J. Case,1 C. Marsh.1

    1Organ Transplantation, Scripps Green Hospital, La Jolla, CA; 2Medical Physics & Radiation Safety, Scripps Green Hospital, La Jolla, CA.

    BACKGROUND: Yttrium-90 (Y-90) radioembolization for the treatment of hepatocellular carcinoma can present safety challenges to the surgeon when transplanting a recently treated Y-90 patient. To…
  • 2018 American Transplant Congress

    T Cell Lineage Imbalance and Regulatory Immune Populations in HCC Patients Undergoing Downstaging While Waitlisted for Liver Transplantation

    P. Thevenot,1 K. Nunez,1 T. Sandow,2 J. Gimenez,2 J. Gonzalez-Rosario,1 M. Patel,1 A. Alfadhli,1 D. Wyczechowska,3 A. Cohen.1

    1Institute of Translational Research, Ochsner Health System, New Orleans, LA; 2Interventional Radiology, Ochsner Health System, New Orleans, LA; 3Stanley S Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA.

    Purpose:In this study, we monitored peripheral lymphocyte lineage and regulatory immune populations in HCC patients undergoing DEB-TACE as a bridge to liver transplantation.Methods: Liver transplant…
  • 2018 American Transplant Congress

    Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence after Liver Transplant

    N. Hendon,1 D. Salerno,1 C. Sammons,1 K. Halazun.2

    1Pharmacy, NewYork-Presbyterian Hospital, New York, NY; 2Surgery, Weill Cornell Medical College, New York, NY.

    Despite limited benefit to patients within Milan criteria on explant, mTORi are routinely utilized for prevention of hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT).…
  • 2018 American Transplant Congress

    Liver Transplantation for Patients with Hepatocellular Carcinoma Presenting beyond Milan Criteria: Analysis of 789 Patients from the US Multicenter HCC Transplant Consortium

    V. Agopian, United States Multicenter HCC Transplant Consortium.

    UCLA, LA.

    Objective: OPTN has recently approved MELD prioritization for HCC patients beyond Milan Criteria (MC) who are downstaged (DS) with locoregional therapy (LRT) prior to liver…
  • 2018 American Transplant Congress

    Liver Transplantation for Hepatocellular Carcinoma Outperform Other Populations in the New Hepatitis C Era

    A. Alsina,1 A. Athienitis,2 J. Buggs,1 E. Fallon,3 E. Parkinson,3 C. Albers,3 N. Kemmer.3

    1Transplantation Surgery, Tampa General Hospital, Tampa, FL; 2Muma College of Business, University of South Florida, Tamoa, FL; 3Transplant Hepatology, Tampa General Hospital, Tampa, FL.

    Background: Long term results of HCC liver transplants (LTx) in the recent era of direct-acting antivirals (DAA) against hepatitis C (HCV) are not available. We…
  • 2018 American Transplant Congress

    Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC

    D. Firl,1 K. Sasaki,1 S. Kimura,2 W. Dumronggittigule,3 A. Gorgen,4 J. Lerut,5 M. Rossi,6 U. Cillo,7 A. Viveiros,8 E. Tsochatzis,9 G. Otto,10 G. Ettorre,11 G. Tisone,12 M. Vivarelli,13 S. Agnes,14 J. Markmann,2 T. Ikegami,15 T. Kaido,16 G. Sapisochin,4 V. Agopian,3 Q. Lai,5,6 F. Aucejo.1

    1CCF, Cleveland; 2MGH, Boston; 3UCLA, LA; 4UHN, Toronto, Canada; 5SLH, Louvain, Belgium; 6UH, Rome, Italy; 7UP, Padua, Italy; 8MUI, Innsbruck, Austria; 9UCL, London, United Kingdom; 10UM, Mainz, Germany; 11SCH, Rome, Italy; 12TVU, Rome, Italy; 13AOU, Torrette Ancona, Italy; 14AGH, Rome, Italy; 15KU, Kyoto, Japan; 16KU, Kyushu, Japan.

    Objective: Prognosticating outcomes in liver transplant (LT) for hepatocellular carcinoma (HCC) continues to challenge the field. Whereas adoption of the binary Milan Criteria (MC) generalized…
  • 2018 American Transplant Congress

    Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation

    M. Xu,1 T. Fraum,2 S. Garcia-Aroz,1 N. Vachharajani,1 N. Saad,3 K. Fowler,2 Y. Lin,1 W. Chapman.1

    1Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St. Louis, MO; 2Department of Radiology, Washington University School of Medicine, St. Louis, MO; 3Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY.

    PURPOSE: The modified response evaluation criteria in solid tumors (mRECIST) has been used to assess the response of hepatocellular carcinoma (HCC) to locoregional therapy (LRT)…
  • 2018 American Transplant Congress

    HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation

    M. Xu, S. Garcia-Aroz, N. Vachharajani, Y. Lin, W. Chapman.

    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St. Louis, MO.

    PURPOSE: The phenomenon of graft versus host disease after orthotopic liver transplantation (OLT) is estimated at approximately 1-2%, suggesting that under some circumstances, the graft…
  • 2018 American Transplant Congress

    Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

    H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, F. Filipponi, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.

    Rigshospitalet, Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark; Hôpital Universitaire Paul Brousse, Villejuif, France; National Institute of Public Health, Copenhagen, Denmark; A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy; Hospital Virgen del Rocio, Sevilla, Spain; Hôpital Universitaire Paul Brousse, Villejuif, France; University of Pisa Medical School Hospital, Pisa, Italy; Hôpital Pontchaillou, Rennes, France; Istituto Nazionale Tumori, Milan, Italy; Beaujon Hospital, Clichy, France; Hospital Clínic, Barcelona, Spain; Hospital Universitari de Bellvitge, Barcelona, Spain; S. Orsola Hospital, Bologna, Italy; King's College Hospital, London, United Kingdom; Hôpital Universitaire Paul Brousse, Villejuif, France; Henri Mondor Hospital, Créteil, France; Rigshospitalet, Copnehagen, Denmark.

    PurposeStudies suggest that vascular invasion may be a superior prognostic marker compared with traditional selection criteria, e.g. Milan criteria. We aimed to investigate the prognostic…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences